# US 2025/0375407 A1 · Methods and Compositions for Treating Ectoparasite Infestations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375407 A1
- Document ID: US20250375407A1
- Status: Published application
- Kind: A1
- Application number: 19/311,280
- Filed: 2025-08-27
- Published: 2025-12-11
- Earliest claimed: 2021-05-13
- Assignees: Nuvo Pharmaceuticals (Ireland) Designated Activity Company
- Applicants: Nuvo Pharmaceuticals (Ireland) Designated Activity Company
- Inventors: Bernard Joseph Chiasson; Robert Patrick Pearce; Chantal Paré
- Web page: https://patentgrep.com/patent/US20250375407A1

## CPC

- A01P 7/04: Insecticides
- A61K 31/23: of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A01N 37/02: Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A01N 55/00: Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur (containing organo-phosphorus compounds A01N57/00)
- A61K 31/80: Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
- A61P 33/14: Ectoparasiticides, e.g. scabicides
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present application includes compositions for treating ectoparasite infestations, including killing ectoparasites and/or their ova, the compositions comprising one or more fatty acid esters and one or more linear polymeric siloxanes. Also included are kits comprising the compositions and methods of treating ectoparasite infestations, including methods of killing ectoparasites and/or their ova, using the compositions.

## Claims

### Claim 1

A composition comprising:
a. one or more fatty acid esters; and
b. one or more linear polymeric siloxanes.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the one or more fatty acid esters are present in an amount of greater than 10 wt % by total weight of the composition.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the one or more linear polymeric siloxanes are present in an amount of less than 65 wt % by total weight of the composition.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the composition comprises one linear polymeric siloxane.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the composition is free of pesticides.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the composition kills greater than 79% of ectoparasite ova in about 24 hours following about 5 minutes to about 10 minutes of topical contact of the composition with a subject.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the one or more fatty acid esters are selected from alkyl esters of fatty acids.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the one or more fatty acid esters are selected from myristate, laurate, palmitate, stearate, arachidate, behenate, lignocerate, palmitoleate, oleate, linoleate, linolenate, and arachidonate.

### Claim 9 (depends on 8)

The composition of claim 8, wherein, the alkyl esters are selected from isopropyl esters, methyl esters, ethyl esters, and propyl esters.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the composition comprises one fatty acid ester.

### Claim 11 (depends on 10)

The composition of claim 10, wherein the one fatty acid ester is isopropyl myristate.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the one or more linear polymeric siloxanes are linear polydialkylsiloxanes.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the one or more linear polymeric siloxanes are polydimethylsiloxanes.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the one or more linear polymeric siloxanes have a viscosity at 25° C. of greater than 1 cSt to less than 90 cSt.

### Claim 15 (depends on 1)

The composition of claim 1, wherein the one or more linear polymeric siloxanes have an average molecular weight (MW) of about 900 g/mol to about 6200 g/mol.

### Claim 16 (depends on 1)

The composition of claim 1, wherein the composition comprises one linear polymeric siloxane.

### Claim 17 (depends on 1)

The composition of claim 1, wherein the composition comprises about 40 wt % to about 60 wt % of the one or more fatty acid esters and about 40 wt % to about 60 wt % of the one or more linear polymeric siloxanes, by total weight of the composition.

### Claim 18 (depends on 1)

The composition of claim 1, wherein a weight ratio of the one or more fatty acid esters to the one or more linear polymeric siloxanes is about 2:1 to about 1:2, or about 1:1.

### Claim 19 (depends on 1)

The composition of claim 1, further comprising excipients, diluents, carriers, cosmetic agents, foaming agents, fragrances agents, and/or skin care agents.

### Claim 20 (depends on 1)

A kit comprising a. one or more compositions of claim 1, and optionally b. instructions for use.

### Claim 21 (depends on 1)

A method for treating an ectoparasite infestation on a subject in need thereof comprising topically administering one or more compositions of claim 1 to the subject.

### Claim 22 (depends on 21)

The method of claim 21, wherein the treating comprises killing the ectoparasites and/or ova of the ectoparasites causing the ectoparasite infestation.

### Claim 23 (depends on 22)

The method of claim 22, wherein the treating comprises killing ova of the ectoparasites that are undeveloped ova, developed ova, half-hatched ova, or combinations thereof.

### Claim 24 (depends on 22)

The method of claim 22, wherein the ectoparasite infestation is caused by ectoparasites selected from head lice, body lice, crab lice, mites, fleas and ticks, and ova and/or larvae thereof.

### Claim 25 (depends on 24)

The method of claim 24, wherein the ectoparasites are head lice.

### Claim 26 (depends on 21)

The method of claim 21, wherein the administering comprises contacting the one or more compositions with an area on the subject where the infestation is present.

### Claim 27 (depends on 26)

The method of claim 26, wherein the area is the scalp, hair or fur of the subject.

### Claim 28 (depends on 26)

The method of claim 26, wherein the contacting is for about 5 minutes to about 40 minutes or about 5 minutes to about 10 minutes.

### Claim 29 (depends on 22)

The method of claim 22, wherein the composition kills greater than 79% of ectoparasite ova in about 24 hours, following the contacting.

### Claim 30 (depends on 21)

The method of claim 21, wherein the one or more compositions are administered as a one-time use.
